Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Netcells is South Africa's leading private stem cell bank, specializing in the collection, processing, and cryogenic storage of umbilical cord blood and tissue. As a division of Next Biosciences, the company provides expectant parents with the opportunity to preserve their newborn's stem cells for potential future medical use in treating over 80 different blood-related and genetic conditions. Netcells operates an internationally accredited laboratory and was the first facility in Africa to receive accreditation from the Association for the Advancement of Blood & Biotherapies (AABB). Their services are integrated with major health insurers like Discovery Health, facilitating access to advanced regenerative medicine and diagnostic screening for families across the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Netcells.